×
About 17,414 results

ALLMedicine™ Mood Disorders Center

Research & Reviews  8,267 results

The efficacy of Alpha-Lipoic Acid in improving oxidative, inflammatory and mood status ...
https://doi.org/10.1111/ijcp.14455
International Journal of Clinical Practice; Rezaei Kelishadi M, Alavi Naeini A et. al.

Jun 9th, 2021 - Migraine is a common neurovascular disorder, which is associated with severe to moderate disabling headaches. Oxidative stress and inflammation might play a role in migraine pathogenesis and the mood disorders. Considering the antioxidant and anti...

Brain-specific heterozygous loss-of-function of ATP2A2, endoplasmic reticulum Ca2+ pump...
https://doi.org/10.1093/hmg/ddab137
Human Molecular Genetics; Nakajima K, Ishiwata M et. al.

Jun 9th, 2021 - A report of a family of Darier's disease with mood disorders drew attention when the causative gene was identified as ATP2A2 (or SERCA2), which encodes a Ca2+ pump on the ER membrane and is important for intracellular Ca2+ signaling. Recently, it ...

Neuroimmunology of depression.
https://doi.org/10.1016/bs.apha.2021.03.004
Advances in Pharmacology (San Diego, Calif.); Sarno E, Moeser AJ et. al.

Jun 8th, 2021 - Depression is one of the leading causes of disability worldwide and a major contributor to the global burden of disease, yet the cellular and molecular etiology of depression remain largely unknown. Major Depressive Disorder (MDD) is associated wi...

Effect of moderate altitude on human cerebral metabolite levels: A preliminary, multi-s...
https://doi.org/10.1016/j.pscychresns.2021.111314
Psychiatry Research. Neuroimaging; Prescot A, Huber R et. al.

Jun 7th, 2021 - Epidemiological studies show that altitude-of-residence is an independent risk factor for worsening rates of mood disorders, substance abuse, and suicide. Proton (1H) magnetic resonance spectroscopy (MRS) studies in rodent models of moderate-to-hi...

Emotional cognition subgroups in mood disorders: Associations with familial risk.
https://doi.org/10.1016/j.euroneuro.2021.05.003
European Neuropsychopharmacology : the Journal of the Eur... Varo C, Kjærstad HL et. al.

Jun 7th, 2021 - Patients with mood disorders show heterogeneity in non-emotional cognition. However, it is unclear whether emotional cognition (EC) is characterised by similar heterogeneity. We aimed to investigate the heterogeneity in EC among remitted patients ...

see more →

Guidelines  41 results

ACOG Committee Opinion No. 757: Screening for Perinatal Depression.
https://doi.org/10.1097/AOG.0000000000002927
Obstetrics and Gynecology;

Jan 10th, 2019 - Perinatal depression, which includes major and minor depressive episodes that occur during pregnancy or in the first 12 months after delivery, is one of the most common medical complications during pregnancy and the postpartum period, affecting on...

Screening for Perinatal Depression
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/Screening-for-Perinatal-Depression

Oct 23rd, 2018 - Perinatal depression, which includes major and minor depressive episodes that occur during pregnancy or in the first 12 months after delivery, is one of the most common medical complications during pregnancy and the postpartum period, affecting on.

Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recomm...
https://www.liebertpub.com/doi/10.1089/jwh.2018.27099.mensocrec
Maki, P.

Sep 4th, 2018 - There is a new appreciation of the perimenopause—defined as the early and late menopause transition stages as well as the early postmenopause—as a window of vulnerability for the development of both depressive symptoms and major depressive episode.

Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the...
https://doi.org/10.1200/JCO.2018.79.2721
Journal of Clinical Oncology : Official Journal of the Am... Lyman GH, Greenlee H et. al.

Jun 11th, 2018 - Purpose The Society for Integrative Oncology (SIO) produced an evidence-based guideline on use of integrative therapies during and after breast cancer treatment that was determined to be relevant to the American Society of Clinical Oncology (ASCO)...

Clinical practice guidelines on the evidence-based use of integrative therapies during ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892208
CA: a Cancer Journal for Clinicians; Greenlee H, DuPont-Reyes MJ et. al.

Apr 24th, 2017 - Answer questions and earn CME/CNE Patients with breast cancer commonly use complementary and integrative therapies as supportive care during cancer treatment and to manage treatment-related side effects. However, evidence supporting the use of suc...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  8,587 results

The efficacy of Alpha-Lipoic Acid in improving oxidative, inflammatory and mood status ...
https://doi.org/10.1111/ijcp.14455
International Journal of Clinical Practice; Rezaei Kelishadi M, Alavi Naeini A et. al.

Jun 9th, 2021 - Migraine is a common neurovascular disorder, which is associated with severe to moderate disabling headaches. Oxidative stress and inflammation might play a role in migraine pathogenesis and the mood disorders. Considering the antioxidant and anti...

Brain-specific heterozygous loss-of-function of ATP2A2, endoplasmic reticulum Ca2+ pump...
https://doi.org/10.1093/hmg/ddab137
Human Molecular Genetics; Nakajima K, Ishiwata M et. al.

Jun 9th, 2021 - A report of a family of Darier's disease with mood disorders drew attention when the causative gene was identified as ATP2A2 (or SERCA2), which encodes a Ca2+ pump on the ER membrane and is important for intracellular Ca2+ signaling. Recently, it ...

Neuroimmunology of depression.
https://doi.org/10.1016/bs.apha.2021.03.004
Advances in Pharmacology (San Diego, Calif.); Sarno E, Moeser AJ et. al.

Jun 8th, 2021 - Depression is one of the leading causes of disability worldwide and a major contributor to the global burden of disease, yet the cellular and molecular etiology of depression remain largely unknown. Major Depressive Disorder (MDD) is associated wi...

Wide Variability in Drugs Used to Manage Conditions Associated With Autism
https://www.medscape.com/viewarticle/952652

Jun 8th, 2021 - NEW YORK (Reuters Health) - There is wide variability in medications prescribed in the United States to manage symptoms and comorbidities associated with autism-spectrum disorder (ASD), a large study has found. Although there is no medical treatme...

Effect of moderate altitude on human cerebral metabolite levels: A preliminary, multi-s...
https://doi.org/10.1016/j.pscychresns.2021.111314
Psychiatry Research. Neuroimaging; Prescot A, Huber R et. al.

Jun 7th, 2021 - Epidemiological studies show that altitude-of-residence is an independent risk factor for worsening rates of mood disorders, substance abuse, and suicide. Proton (1H) magnetic resonance spectroscopy (MRS) studies in rodent models of moderate-to-hi...

see more →

News  479 results

Wide Variability in Drugs Used to Manage Conditions Associated With Autism
https://www.medscape.com/viewarticle/952652

Jun 8th, 2021 - NEW YORK (Reuters Health) - There is wide variability in medications prescribed in the United States to manage symptoms and comorbidities associated with autism-spectrum disorder (ASD), a large study has found. Although there is no medical treatme...

New Data on Worldwide Mental Health Impact of COVID-19
https://www.medscape.com/viewarticle/947458

Mar 14th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A new survey that assessed the mental health impact of COVID-19 across the globe shows high rates of trauma and clinical mood disorders related to...

Cannabis Tied to Self-Harm, Death in Youth With Mood Disorders
https://www.medscape.com/viewarticle/945030

Jan 31st, 2021 - Adolescents and young adults with mood disorders and cannabis use disorder (CUD) are at significantly increased risk for self-harm, all-cause mortality, homicide, and death by unintentional overdose, new research suggests. Investigators found the ...

New Risks of Prescription Opioids Discovered
https://www.medscape.com/viewarticle/941170

Nov 16th, 2020 - Prescription opioid use increases the risk for major depressive disorder (MDD) and anxiety and stress-related disorders (ASRD), new genetic evidence shows. The findings also suggest MDD is a potential causal risk factor for increased prescription ...

Depression or Anxiety? Metabolic Blood Biomarkers May Tell the Tale
https://www.staging.medscape.com/viewarticle/938079

Sep 24th, 2020 - Metabolic alterations linked to inflammation and lipid metabolism can distinguish depression from anxiety and determine disease severity, new research suggests.  Results from a Dutch study included 1400 participants with anxiety, depression, or bo...

see more →

Patient Education  37 results see all →